
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum
Jansy P. Sarathy, Min Xie, R. Mark Jones, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 23
Jansy P. Sarathy, Min Xie, R. Mark Jones, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 23
Showing 23 citing articles:
A Physiologically Relevant In Vitro Model of Nonreplicating Persistent Mycobacterium tuberculosis in Caseum
Min Xie, Paulina Osiecki, Sergio D. Rodríguez, et al.
Current Protocols (2025) Vol. 5, Iss. 3
Open Access | Times Cited: 1
Min Xie, Paulina Osiecki, Sergio D. Rodríguez, et al.
Current Protocols (2025) Vol. 5, Iss. 3
Open Access | Times Cited: 1
Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses
Nicholas D. Walter, Jacqueline P. Ernest, Christian Dide-Agossou, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 9
Open Access | Times Cited: 19
Nicholas D. Walter, Jacqueline P. Ernest, Christian Dide-Agossou, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 9
Open Access | Times Cited: 19
Tuberculosis treatment-shortening
Vinayak Singh
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103955-103955
Open Access | Times Cited: 7
Vinayak Singh
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103955-103955
Open Access | Times Cited: 7
Toward better cures for Mycobacterium abscessus lung disease
Véronique Dartois, Thomas Dick
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 4
Véronique Dartois, Thomas Dick
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 4
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant M. abscessus in caseum surrogate
Min Xie, Uday S. Ganapathy, Tian Lan, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 9
Open Access | Times Cited: 10
Min Xie, Uday S. Ganapathy, Tian Lan, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 9
Open Access | Times Cited: 10
Candidate transmission survival genome ofMycobacterium tuberculosis
Saurabh Mishra, Prabhat Ranjan Singh, Xiaoyi Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Saurabh Mishra, Prabhat Ranjan Singh, Xiaoyi Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Candidate transmission survival genome of Mycobacterium tuberculosis
Saurabh Mishra, Prabhat Ranjan Singh, Xiaoyi Hu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
Saurabh Mishra, Prabhat Ranjan Singh, Xiaoyi Hu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 10
Open Access
Contribution of front-line, standard-of-care drugs to bactericidal responses, resistance emergence, and cure in murine models of easy- or hard-to-treat tuberculosis disease
Nathan Peroutka‐Bigus, Elizabeth J. Brooks, Michelle E. Ramey, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
Nathan Peroutka‐Bigus, Elizabeth J. Brooks, Michelle E. Ramey, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access
ACTG A5409 (RAD-TB): Study Protocol for a Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Linda J. Harrison, Gustavo E. Velásquez, Russell R. Kempker, et al.
Research Square (Research Square) (2025)
Closed Access
Linda J. Harrison, Gustavo E. Velásquez, Russell R. Kempker, et al.
Research Square (Research Square) (2025)
Closed Access
Toward a Bactericidal Oral Drug Combination for the Treatment of Mycobacterium abscessus Lung Disease
Jickky Palmae Sarathy, Min Xie, Chui Fann Wong, et al.
ACS Infectious Diseases (2025)
Open Access
Jickky Palmae Sarathy, Min Xie, Chui Fann Wong, et al.
ACS Infectious Diseases (2025)
Open Access
Rankings of tuberculosis antibiotic treatment regimens are sensitive to spatial scale, detection limit, and initial host bacterial burden
Christian Michael, Maral Budak, Pauline Maiello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Christian Michael, Maral Budak, Pauline Maiello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
TheMycobacterium tuberculosislong-chain fatty acid resistome reveals the universal stress protein TB15.3 as essential for infection
António Pinto, Marco Silva, Joana A. Santos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
António Pinto, Marco Silva, Joana A. Santos, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Primary tuberculous mycobacterial granulomas provide a niche for superinfecting Mycobacterium abscessus
Denise Wee, Manitosh Pandey, Yao Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Denise Wee, Manitosh Pandey, Yao Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
In silico agent-based modeling approach to characterize multiple in vitro tuberculosis infection models
Alexa Petrucciani, Alexis Hoerter, Leigh A. Kotzé, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299107-e0299107
Open Access | Times Cited: 2
Alexa Petrucciani, Alexis Hoerter, Leigh A. Kotzé, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299107-e0299107
Open Access | Times Cited: 2
Role of DNA Double-Strand Break Formation in Gyrase Inhibitor-Mediated Killing of Nonreplicating Persistent Mycobacterium tuberculosis in Caseum
Priyanka Ashwath, Paulina Osiecki, Danielle M. Weiner, et al.
ACS Infectious Diseases (2024)
Open Access | Times Cited: 2
Priyanka Ashwath, Paulina Osiecki, Danielle M. Weiner, et al.
ACS Infectious Diseases (2024)
Open Access | Times Cited: 2
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis
Allison Bauman, Jansy P. Sarathy, Firat Kaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Allison Bauman, Jansy P. Sarathy, Firat Kaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Environmental fungi target thiol homeostasis to compete with Mycobacterium tuberculosis
Neha Malhotra, Sangmi Oh, Peter Finin, et al.
PLoS Biology (2024) Vol. 22, Iss. 12, pp. e3002852-e3002852
Open Access | Times Cited: 1
Neha Malhotra, Sangmi Oh, Peter Finin, et al.
PLoS Biology (2024) Vol. 22, Iss. 12, pp. e3002852-e3002852
Open Access | Times Cited: 1
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 2
Alessio Lanni, Angelo Iacobino, Lanfranco Fattorini, et al.
Microorganisms (2023) Vol. 11, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 2
Environmental sphagnum-associated fungi target thiol homeostasis to compete with Mycobacterium tuberculosis.
Neha Malhotra, Sangmi Oh, Peter Finin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Neha Malhotra, Sangmi Oh, Peter Finin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis
Allison Bauman, Jansy P. Sarathy, Firat Kaya, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Allison Bauman, Jansy P. Sarathy, Firat Kaya, et al.
Antimicrobial Agents and Chemotherapy (2024)
Open Access
Molecular and microbiological methods for the identification of nonreplicating Mycobacterium tuberculosis
Jansy P. Sarathy
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012595-e1012595
Open Access
Jansy P. Sarathy
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012595-e1012595
Open Access
The kinetics of bedaquiline diffusion in tuberculous cavities opens a window for emergence of resistance.
Annamarie E. Bustion, Jacqueline P. Ernest, Firat Kaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Annamarie E. Bustion, Jacqueline P. Ernest, Firat Kaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters
Hassan E. Eldesouky, Richard M. Jones, Natalie S. Gleason, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hassan E. Eldesouky, Richard M. Jones, Natalie S. Gleason, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access